Moleculin Biotech is trading 6.15% down at $0.49 after closing at $0.52 on August 12, 2026, following a sharp regular-session gain and after-hours reversal.
- No verified company-specific announcement dated August 12, 2026 was identified.
- Recent financing involved a $9.3 million offering completed August 3; broader markets were positive, so neither clearly explains the decline.